Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Genscript Biotech Corp
(OP:
GNNSF
)
2.350
UNCHANGED
Streaming Delayed Price
Updated: 10:39 AM EDT, Jun 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.350
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
2.350
Today's Range
2.350 - 2.350
52wk Range
2.210 - 3.530
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 DNA Stocks to Buy for the Synthetic Biology Revolution
May 14, 2023
Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.
Via
InvestorPlace
The Next Big Disruptors? 3 Biotech Stocks Making Headlines.
February 17, 2023
Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023.
Via
InvestorPlace
Performance
YTD
-31.69%
-31.69%
1 Month
-9.62%
-9.62%
3 Month
-8.56%
-8.56%
6 Month
-21.67%
-21.67%
1 Year
-32.18%
-32.18%
More News
Read More
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
January 21, 2023
Via
Talk Markets
Three Pharma Stocks to Sell Before They Die
December 24, 2022
Via
InvestorPlace
Week In Review: Akeso Out-Licenses PD-1/VEGF To Summit In $5 Billion Pact
December 10, 2022
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.